Abbott Laboratories (ABT) Tops Q2 EPS by 1c; Raises FY11 Outlook
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $94.12 +0.94%
Revenue Growth %: +9.8%
Financial Fact:
Total Operating Cost and Expenses: 4.41B
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: +9.8%
Financial Fact:
Total Operating Cost and Expenses: 4.41B
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Abbott Laboratories (NYSE: ABT) reported Q2 EPS of $1.12, $0.01 better than the analyst estimate of $1.11. Revenue for the quarter came in at $9.62 billion versus the consensus estimate of $9.56 billion.
Sees FY2011 EPS of $4.58-$4.68, versus prior guidance of $4.54-$4.64 and the consensus of $4.60.
Sees FY2011 EPS of $4.58-$4.68, versus prior guidance of $4.54-$4.64 and the consensus of $4.60.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron Technology (MU) Tops Q3 EPS by $4.62, Guidance Beats
- Darden Restaurants (DRI) Tops Q4 EPS by 3c, Misses on Revenue; Offers FY27 Guidance
- H.B. Fuller (FUL) Tops Q2 EPS by 3c; Offers Outlook
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
